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Abstract 
Aims 
This review aimed at investigating the effect of membrane exposure on guided bone 
regeneration (GBR) outcomes at peri‐implant sites and edentulous ridges.  
Material and Methods 
Electronic and manual literature searches were conducted by two independent reviewers using 
four databases, including MEDLINE, EMBASE, Web of Science, and Cochrane Central 
Register of Controlled Trials, for articles up to February 2017. Articles were included if they 
were human clinical trials or case series reporting outcomes of GBR procedures with and 
without membrane exposure. A random‐effects meta‐analysis was conducted, and the 
weighted mean difference (WMD) between the two groups and 95% confidence interval (CI) 
were reported.  
Results 
Overall, eight articles were included in the quantitative analysis. The WMD of the horizontal 
bone gain at edentulous ridges was −76.24% (95% CI = −137.52% to −14.97%, p = .01) 
between sites with membrane exposure and without exposure. In addition, the WMD of the 
dehiscence reduction at peri‐implant sites was −27.27% (95% CI of −45.87% to −8.68%, 
p = .004). Both analyses showed significantly favorable outcomes at the sites without 
membrane exposure.  
Conclusion 
Based on the findings of this study, membrane exposure after GBR procedures has a 
significant detrimental influence on the outcome of bone augmentation. For the edentulous 
ridges, the sites without membrane exposure achieved 74% more horizontal bone gain than 
the sites with exposure. For peri‐implant dehiscence defects, the sites without membrane 
exposure had 27% more defect reduction than the sites with exposure.  
1 INTRODUCTION 
Alveolar ridge dimensions provide the foundation for primary implant stability and long‐term 
implant success. Bone deficiencies present an immediate concern for clinicians and need to be 
addressed early in the treatment planning process. The etiology of ridge deficiencies can be 
either anatomic or pathologic in nature, as described by Buser, Martin, and Belser (2004). In 
an attempt to standardize defect parameters, several authors have developed classification 
systems (Allen, Gainza, Farthing, & Newbold, 1985; Seibert, 1983; Wang & Al‐Shammari, 
2002). Each author described three different types of ridge deficiencies based on the 
progression of the ridge resorption following edentulism: horizontal, vertical, and a combination 
of the two dimensions. When evaluating an edentulous site for future implant placement, ideal 
treatment outcomes demand sufficient horizontal and vertical ridge dimensions. To prevent 
further bone remodeling after implant placement, Spray, Black, Morris, and Ochi (2000) 
proposed a need for 1.8 mm of bone thickness at the buccal aspect of the implant and 0.5 mm 
at the palatal aspect to ensure long‐term success. In addition, Tarnow, Cho, and Wallace 
(2000) also recommended a need for at least 1.5 mm of distance between an implant and the 
adjacent root, and at least 3 mm of distance between two adjacent implants, to accommodate 
ideal interproximal bone levels as well as for papilla support.  
Several techniques have been proposed and widely used to augment deficient ridges. Guided 
bone regeneration (GBR) is one of the most utilized techniques, and it consists of using 
grafting materials in combination with a barrier, either a nonresorbable membrane (Buser, 
Bragger, Lang, & Nyman, 1990) or an absorbable membrane (Mellonig & Nevins, 1995). Other 
techniques include the use of a bone block graft (Misch, 1997) or a ridge‐split technique 
(Simion, Baldoni, & Zaffe, 1992). Additionally, the use of distraction osteogenesis to augment 
the edentulous ridge has also been proposed (Chiapasco, Romeo, & Vogel, 2001; Chin, 1999). 
Recently, the “sandwich” technique has been described to regenerate horizontal and vertical 
bone defects at peri‐implant sites (Wang, Misch, & Neiva, 2004). All these techniques are 
effective; however, complications can occur during the healing phase of treatment, creating 
undesired outcomes.  
Successful GBR procedures are dependent on four fundamental principles that must ensue 
during the surgery and throughout healing. These principles consist of primary closure, 
angiogenesis, space maintenance, and stability of the wound, the so‐called PASS principle 
(Wang & Boyapati, 2006). Complications with any of these principles can result in premature 
membrane exposure that potentially compromises the regenerative process. To minimize the 
risk of complications, clinicians should assess the amount of keratinized mucosa, tissue 
biotype, vestibular depth, flap flexibility, bone defect type and size, and type of membrane 
used (Chao, Chang, Fu, Wang, & Chan, 2015). Each one of these factors has been identified 
as a contributing factor in membrane exposure.  
As there is a need to understand the influence of membrane exposure on GBR outcomes, the 
goal of this study was to compare the amount of bone gain after GBR procedures between 
sites with and without membrane exposure. The primary outcome was the percentage of 
horizontal bone gain at edentulous ridges. The secondary outcome was the percentage of peri‐
implant bone dehiscence reduction at peri‐implant sites.  
2 MATERIAL AND METHODS 
2.1 Focused question 
What is the effect of membrane exposure on bone augmentation outcomes after horizontal 
ridge augmentation at edentulous sites after GBR procedures or at peri‐implant sites 
immediately after implant placement?  
2.2 PICO question (problem, intervention, comparison, outcome) 
P: Maxillary or mandibular partially edentulous healthy subjects who were to receive or had 
received dental implants to restore oral function  
I: GBR for horizontal ridge augmentation to augment bone width for future implant placement 
or to restore peri‐implant dehiscence defects immediately after implant placement  
C: GBR outcomes between sites with and without membrane exposure 
O:  
• Primary outcome: percentage of horizontal bone gain at sites with and without 
membrane exposure at edentulous ridges  
• Secondary outcome: percentage of peri‐implant bone dehiscence reduction at sites with 
and without membrane exposure at peri‐implant sites  
2.3 Information sources 
Electronic and manual literature searches were conducted by two independent reviewers (JG 
and AD) in four databases, including MEDLINE, EMBASE, Web of Science, and Cochrane 
Central Register of Controlled Trials, for articles up to February 2017. Two reviewers 
independently extracted the data from studies (JG and AD). Publications that did not meet the 
inclusion criteria were excluded. In case of disagreements, consensus was reached by 
discussion with a third reviewer (GL).  
2.4 Screening process and data extraction 
For the PubMed library, combinations of controlled terms ([mh] represented MeSH terms) and 
keywords ([tiab] represented title/abstract search and [all] represented full‐text search) were 
used whenever possible. As such, the key terms used were as follows:  
(“alveolar ridge augmentation”[all] OR “ridge augmentation”[all] OR “guided bone 
regeneration”[all]) 
AND 
(“dental implants”[mh] OR “absorbable implants”[mh] OR implant [tiab] OR implants [tiab]) AND  
(“complication”[all] OR “complications”[all] OR “exposure”[all]) 
For the other databases, the key terms used for the search included GBR, alveolar ridge 
augmentation, dental implants, complication, and exposure.  
The screening in such databases was limited to “clinical studies” AND “humans” in all of the 
screening strategies. In addition, an electronic screening of the grey literature at the New York 
Academy of Medicine Grey Literature Report (http://greylit.org) and Google Scholar was 
conducted as recommended by high standards for systematic reviews, that is Assessment of 
Multiple Systematic Reviews (AMSTAR) guidelines (Shea et al., 2007).  
Additionally, a manual search of periodontics‐related journals, including Clinical Implant 
Dentistry and Related Research, The International Journal of Oral & Maxillofacial Implants, 
Clinical Oral Implants Research, Implant Dentistry, European Journal of Oral Implantology, 
Journal of Implantology, International Journal of Oral and Maxillofacial Surgery, Journal of Oral 
and Maxillofacial Surgery, Journal of Dental Research, Journal of Clinical Periodontology, 
Journal of Periodontology, and The International Journal of Periodontics & Restorative 
Dentistry, from January 2016 up to March 2017, was performed to ensure a thorough 
screening process. This systematic review was registered at the PROSPERO website 
(registration number: CRD42017059598).  
2.5 Inclusion criteria 
Studies were included for the review if the following inclusion criteria were fulfilled: clinical 
human prospective or retrospective study, number of study sites of ≥10, GBR procedure for 
ridge augmentations at partially edentulous ridges or peri‐implant defects immediately after 
implant placement. Studies with nonparticulate bone grafting materials (i.e., block grafts), no 
information regarding complications, augmentation procedures other than GBR (distraction 
osteogenesis, sinus lifts, etc.), vertical ridge augmentation, and treatment of peri‐implantitis 
were excluded from this study. Article titles and abstracts were screened first for inclusion 
eligibility.  
2.6 Data extraction 
Data recorded for each study included the study design, number of participants, bone grafting 
materials used, membrane type selected, initial bone width, final bone width, timing of 
complication onset, and duration of follow‐up after the augmentation surgery.  
2.7 Data analyses 
The primary outcome was the percentage of horizontal bone gain at edentulous sites in groups 
with and without membrane exposure. The secondary outcome was the percentage of 
dehiscence defect reduction at peri‐implant sites in groups with and without membrane 
exposure. The pooled weighted mean difference (WMD) of the percentage of horizontal bone 
changes at edentulous sites, and the percentage defect depth reduction at peri‐implant sites 
was estimated using a computer program (RevMan version 5.0, The Nordic Cochrane Centre, 
The Cochrane Collaboration, Copenhagen, 2008). The contribution of each article was 
weighed. Random effects meta‐analyses were applied to the selected studies to manage the 
inherent variability of results due to a great variety of study designs employed by different 
research groups. Forest plots were generated to graphically represent the difference in primary 
and secondary outcomes for all included studies using augmented sites as the analysis unit. A 
p value = .05 was used as the level of significance. Heterogeneity was assessed with a chi‐
square test and I2 test. Heterogeneity values range between 0% and 100%, where lower 
values represent less heterogeneity. In addition, funnel plots were used to assess the 
presence of publication bias. The data presented in this systematic review adhere to the 
PRISMA (Preferred Reporting Items for Systematic Review and Meta‐Analyses) statement 
(Liberati et al., 2009).  
2.8 Risk of bias assessment 
The criteria used to assess the quality of the selected randomized control trials (RCTs) were 
modified from the checklist of the Cochrane Center (Higgins & Green, 2011). For non‐RCTs, 
the Methodological Index for Non‐Randomized Studies (MINORS) was used to rank the risk of 
bias of the included studies (Slim et al., 2003). The degree of bias was categorized as follows: 
low risk if all the criteria were met, moderate risk when only one criterion was missing, and 
high risk if two or more criteria were missing. Two reviewers (JG and GL) assessed all the 
included articles independently.  
3 RESULTS 
3.1 Data extraction 
A total of 837 records were identified through the electronic and manual search process after 
exclusion of duplicates (Figure 1). Of these, 795 were screened based on the title and/or 
abstract content, and 42 were selected for full‐text assessment and inclusion in the qualitative 
evaluation. Finally, 34 studies (Antoun, Sitbon, Martinez, & Missika, 2001; von Arx & Buser, 
2006; von Arx & Kurt, 1999; Assenza et al., 2001; Bahat & Fontanessi, 2001; Buser, Dula, Hirt, 
& Schenk, 1996; Chiapasco, Autelitano, Rabbiosi, & Zaniboni, 2013; Cordaro, Amade, & 
Cordaro, 2002; Cordaro, Torsello, Morcavallo, & di Torresanto, 2011; Friedmann, Strietzel, 
Maretzki, Pitaru, & Bernimoulin, 2002; Her, Kang, & Fien, 2012; Kfir, Kfir, & Kaluski, 2007; Lee, 
Kim, Yi, & Choi, 2013; Lindfors, Tervonen, Sandor, & Ylikontiola, 2010; Lizio, Corinaldesi, & 
Marchetti, 2014; Lorenzoni, Pertl, Polansky, Jakse, & Wegscheider, 2002; Louis, Gutta, Said‐
Al‐Naief, & Bartolucci, 2008; Lyford, Mills, Knapp, Scheyer, & Mellonig, 2003; Mattout & 
Mattout, 2000; Meloni et al., 2017; Merli et al., 2015; Miyamoto, Funaki, Yamauchi, Kodama, & 
Takahashi, 2012; Park, Brooks, Oh, & Wang, 2009; Parodi, Carusi, Santarelli, & Nanni, 1998; 
Proussaefs & Lozada, 2003, 2006; Proussaefs, 2003; Sethi & Kaus, 2001; Torres et al., 2010; 
Uehara et al., 2015; Urban, Nagursky & Lozada, 2011; Urban, Nagursky, Lozada, & Nagy, 
2013; Wessing, Emmerich, & Bozkurt, 2016; Zitzmann, Naef, & Scharer, 1997) were excluded 
from the quantitative analysis due to lack of data, and eight studies (Annibali, Bignozzi, 
Sammartino, La Monaca, & Cristalli, 2012; Buser et al., 1990; Chiapasco, Abati, Romeo, & 
Vogel, 1999; Fu, Oh, Benavides, Rudek, & Wang, 2014; Gher, Quintero, Assad, Monaco, & 
Richardson, 1994; Nowzari & Slots, 1995; Park et al., 2008; Tawil, El‐Ghoule, & Mawla, 2001) 
that reported on the primary and secondary outcomes were meta‐analyzed. The kappa value 
between the two reviewers was 0.92 for titles and abstract evaluation, and 0.88 for full‐text 
evaluation. The reasons for exclusion of specific studies are noted in Table S1, and the main 
features of the included studies are summarized in Table 1.  
 
Figure 1  
PRISMA flowchart demonstrates the inclusion studies selection process 
 
Table 1. Characteristics of the included studies  
• NA, not available/applicable; GBR, guided bone regeneration; RCT, randomized 
controlled trial; PCS: prospective case series; RCS, retrospective case series; Auto, 
autogenous bone graft; Allo, allograft; Xeno: xenograft; Combo, combination grafts; N, 
nonresorbable membrane; R, absorbable membrane.  
3.2 Features of the included studies 
3.2.1 Study design and patient features 
Three RCTs (Fu et al., 2014; Gher et al., 1994; Park et al., 2008), four prospective case series 
(PCS; Buser et al., 1990; Chiapasco et al., 1999; Nowzari & Slots, 1995; Tawil et al., 2001), 
and one retrospective case series (RCS; Annibali et al., 2012) were included in this study. The 
age range of the patients in the selected studies was 17–85 years. All the studies indicated the 
participants were systemically healthy, and only six studies (Annibali et al., 2012; Chiapasco 
et al., 1999; Fu et al., 2014; Gher et al., 1994; Nowzari & Slots, 1995; Park et al., 2008) 
provided more detailed exclusion criteria: Annibali et al. (2012) and Park et al. (2008) excluded 
patients who smoked 10 or more cigarettes a day and patients with full‐mouth plaque and 
bleeding scores of >25%; Chiapasco et al. (1999) excluded heavy smokers, alcohol abusers, 
patients with poor oral hygiene or active periodontal disease, history of head and neck 
malignancies, uncontrolled diabetes, severe liver or renal disease, and immune system 
disorders; Fu et al. (2014) excluded all patients who were smokers, pregnant, or had unstable 
periodontal diseases, or a history of drug or alcohol abuse; Gher et al. (1994) excluded 
pregnant patients; and Nowzari and Slots (1995) excluded patients who had antibiotic therapy 
within 6 months of the study period. Two studies (Annibali et al., 2012; Chiapasco et al., 1999) 
included patients who were light smokers (<10 cigarettes per day).  
The initial bone dimensions were provided by most of the studies, except for three (Fu et al., 
2014; Gher et al., 1994; Park et al., 2008). The follow‐up period after the GBR procedures, 
ranging from 4 to 14 months, was reported by all the included studies. Among the included 
articles, all studies reported no conflict of interest, except one study (Park et al., 2008), which 
reported a conflict of interest with two private corporations.  
3.2.2 Types of membranes used 
All the included studies used barrier membranes for GBR procedures. Only two studies (Buser 
et al., 1990; Chiapasco et al., 1999) that measured horizontal bone gain at edentulous ridges 
utilized expanded polytetrafluoroethylene (e‐PTFE) membranes. Of the studies analyzing the 
reduction in bone dehiscences at peri‐implant sites, two studies (Gher et al., 1994; Nowzari & 
Slots, 1995) exclusively used e‐PTFE membranes. One study (Annibali et al., 2012) used 
either titanium‐reinforced e‐PTFE or absorbable membranes; however, all membrane 
exposures occurred at sites with e‐PTFE barriers. The other three studies (Fu et al., 2014; 
Park et al., 2008; Tawil et al., 2001) only used absorbable membranes. Tawil et al. (2001) 
used an absorbable collagen membrane, Park et al. (2008) used either an acellular dermal 
matrix (ADM) or a collagen membrane, and Fu et al. (2014) introduced a bovine pericardium 
membrane for GBR procedures.  
3.2.3 Types of bone grafting materials used 
All included studies, except for one (Nowzari & Slots, 1995), reported the grafting materials 
used for the GBR procedures. For studies that measured horizontal bone gain at edentulous 
sites, one (Chiapasco et al., 1999) used autogenous bone grafts and the other (Buser et al., 
1990) did not use bone grafting material at all. In terms of studies that analyzed dehiscence 
reduction at peri‐implant sites, one study (Tawil et al., 2001) solely used autogenous cortical 
bone, another study (Gher et al., 1994) used demineralized freeze‐dried bone allograft 
(DFDBA), two other studies (Fu et al., 2014; Park et al., 2008) used mineralized allograft, and 
the other one study (Annibali et al., 2012) used a combination of autogenous bone chips and 
DFDBA or bovine xenograft.  
3.3 Incidence of membrane exposure 
For all studies, the exposure of the membrane was clinically detected during the follow‐up 
period. The exposure resulted in surgical removal of the membrane in all but four studies (Fu 
et al., 2014; Gher et al., 1994; Park et al., 2008; Tawil et al., 2001). Gher et al. (1994) 
attributed the exposure, which occurred during the first 2 weeks postoperatively, to 
inappropriate trimming of the membrane, and used 0.12% chlorhexidine rinses for the duration 
of the healing time. Two weeks postoperatively, Tawil et al. (2001) resutured the flaps to gain 
closure and did so without removing the membrane. Park et al. (2008) had five sites with 
collagen membrane exposure and two sites with ADM exposure. Fu et al. (2014) had three 
patients with partial cover screw exposure at 2 weeks, yet the surgical site closed completely 
at the 1‐month re‐evaluation. The remaining studies reported membrane exposures from 8 to 
10 days to 36 weeks postoperatively. Of these, the adverse events of the exposure were 
reported in two studies: Buser et al. (1990) reported unusual edema, and Nowzari and Slots 
(1995) reported inflammation, suppuration, and pain. The other two studies (Annibali et al., 
2012; Chiapasco et al., 1999) did not comment on the events of the membrane exposure.  
3.4 Meta‐analysis of the primary outcome & secondary outcome 
As the size of the initial bone defect impacts the amount of defect reduction, only studies 
reporting the percentage of bone defect reduction were pooled for comparable comparisons.  
Two studies (Buser et al., 1990; Chiapasco et al., 1999) reported outcomes on the percentage 
of horizontal bone gain after GBR at edentulous sites with and without membrane exposure. 
Meta‐analysis showed a statistically significant difference (WMD = −76.24%, with a 95% CI of 
−137.52% to −14.97%, p = .01, Figure 2) between the two groups, favoring the group without 
membrane exposure. A moderate level of heterogeneity was seen (p value for chi‐square 
test = .15 and I2 test = 51%) among the pooled studies.  
 
Figure 2  
Forest plots representing the outcomes of the percentage of horizontal bone width gain after 
GBR at edentulous ridges between groups with and without membrane exposure. Meta‐
analysis showed a statistically significant difference (WMD = −76.24%, with a 95% CI of 
−137.52% to −14.97%, p = .01), favoring the group without membrane exposure  
Five studies (Annibali et al., 2012; Fu et al., 2014; Nowzari & Slots, 1995; Park et al., 2008; 
Tawil et al., 2001) reported outcomes on the percentage of bone dehiscence reduction after 
GBR at peri‐implant sites. Meta‐analysis showed a statistically significant difference 
(WMD = −27.27%, with a 95% CI of −45.87% to −8.68%, p = .004, Figure 3) between the two 
groups, favoring the group without membrane exposure. A high level of heterogeneity was 
seen (p value for chi‐square test = .0001 and I2 test = 83%) among the pooled studies. 
Subgroup analysis based on the type of membranes used was also conducted. For the 
nonresorbable membrane subgroup, two studies (Annibali et al., 2012; Nowzari & Slots, 1995) 
were pooled and meta‐analysis showed no statistically significant difference (WMD = −24.56%, 
with a 95% CI of −71.55% to 22.42%, p = .31). However, this subgroup analysis also revealed 
a high level of heterogeneity between the two studies (p value for chi‐square test <.0007 and I2 
test = 91%). For the absorbable membrane subgroup, three studies (Fu et al., 2014; Park 
et al., 2008; Tawil et al., 2001) were included, and these revealed a statistically significant 
difference (WMD = −31.83%, with a 95% CI of −40.95% to −22.72%, p < .0001), favoring the 
group without membrane exposure. This subgroup analysis revealed a low level of 
heterogeneity among the pooled studies (p value for chi‐square test = .99 and I2 test = 0%). 
Funnel plots for the analysis of edentulous ridges and peri‐implant sites were reported as 
Figures S1 and S2.  
 
Figure 3  
Forest plots representing the outcomes of the percentage of peri‐implant bone dehiscence 
reduction after GBR between groups with and without membrane exposure. Meta‐analysis 
showed a statistically significant difference (WMD = −27.27%, with a 95% CI of −45.87% to 
−8.68%, p = .004), favoring the group without membrane exposure  
3.5 Risk of bias assessment 
The results of the risk of bias assessment for included case series are summarized in Table 2 
(RCT) and Table 3 (non‐RCTs). One RCT (Gher et al., 1994) and one case series (Annibali 
et al., 2012) were considered to have a high risk of bias. Another RCT (Fu et al., 2014) and 
four case series (Buser et al., 1990; Chiapasco et al., 1999; Nowzari & Slots, 1995; Tawil 
et al., 2001) were considered to have a moderate risk of bias. One other RCT was considered 
to have a low risk of bias (Park et al., 2008). The kappa value of the interexaminer agreement 
for risk of bias assessment was 1.00.  
 
 
 
 
 Table 2. Risk of bias assessment for the included RCT  
Criteria, Higgins, and Green (2011)  Gher et al. (1994)  
Park et al. 
(2008)  
Fu et al. 
(2014)  
Sequence generation Yes Yes Yes 
Randomization methods RCT RCT RCT 
Allocation concealment method ? Yes Yes 
Examiner masked ? Yes No 
All patients accounted for at end of study Yes Yes Yes 
Incomplete outcome data adequately 
addressed Yes Yes Yes 
Free of suggestion of selective outcome 
reporting Yes Yes Yes 
Estimated potential risk of bias High Low Moderate 
• ?, Not reported.  
Table 3. Risk of bias assessment for the included case series using the Methodological Index 
for Non‐Randomized Studies (MINORS)  
 
Criteria, Slim et al. 
(2003)  
Buser et al. 
(1990)  
Nowzari and 
Slots (1995)  
Chiapasco 
et al. (1999)  
Tawil et al. 
(2001)  
Annibali 
et al. (2012)  
A clearly stated aim 2 2 2 2 2 
Inclusion of 
consecutive patients 2 2 2 2 2 
Prospective collection 
of data 2 2 2 2 0 
Endpoints appropriate 
to the aim of the study 2 2 2 2 2 
Unbiased assessment 
of the study endpoint 2 2 2 2 2 
Follow‐up period 
appropriate to the aim 
of the study 
2 2 2 2 2 
Loss to follow‐up less 
than 5% 2 2 2 2 2 
Prospective calculation 
of the study size 0 0 0 0 0 
Criteria, Slim et al. 
(2003)  
Buser et al. 
(1990)  
Nowzari and 
Slots (1995)  
Chiapasco 
et al. (1999)  
Tawil et al. 
(2001)  
Annibali 
et al. (2012)  
Estimated potential risk 
of bias Moderate Moderate Moderate Moderate High 
• 2, Adequate; 1, Inadequate; 0, Not reported.  
4 DISCUSSION 
In 2001, Machtei (2001) investigated the effect of early membrane exposure on guided tissue 
and bone regeneration. The results of the study showed a difference of six times greater bone 
gain if the healing period did not have early membrane exposure. One of the main drawbacks 
of that investigation was that only two papers were included in the assessment. Furthermore, 
the results of the study were reported in millimeters instead of percentages of bone gain, 
potentially introducing issues with the validity of the comparisons. Without identifying the 
dimensions of the initial defect size, the amount of potential bone gain measured between the 
groups could yield incomparable datasets. For example, one of the included studies (Annibali 
et al., 2012) reported an average of 5.00 mm of bone gain for sites with membrane exposure, 
which is greater than the 3.19 mm gained at sites without membrane exposure. While this 
seems to suggest almost 2 mm of difference between the groups, when analyzed by the 
percentage of defect reduction, the two groups showed comparable percentages of defect 
reduction, 90.82% for sites without membrane exposure, and 87.50% for sites with exposure, 
respectively. In order to compare the outcomes more meaningfully and to avoid potentially 
biased analyses, we used the percentage of horizontal bone gain/dehiscence reduction 
instead of linear measurements as our study outcomes.  
The objective of using a barrier membrane is to prevent the ingrowth of soft tissue, while 
providing space for the graft and allowing oxygen and nutrients to enter the grafted site 
(Rakhmatia, Ayukawa, Furuhashi, & Koyano, 2013). Prior to our study, no meta‐analysis has 
been performed to compare the resulting bone gain of edentulous sites under exposed and 
nonexposed GBR membranes. We found that the sites without membrane exposure achieved 
74% more horizontal bone gain than those with exposure. However, it is worth mentioning that 
the two articles (Annibali et al., 2012; Nowzari & Slots, 1995) exclusively used e‐PTFE barriers 
instead of dense PTFE (d‐PTFE) barriers. The difference in bacterial resistance between e‐
PTFE and d‐PTFE (d‐PTFE being more resistant) could be significant. Studies have shown 
that intentionally exposed d‐PTFE membranes for socket preservation procedures (Greenstein 
& Carpentieri, 2015) as well as GBR procedures (Hoffmann et al., 2008; Waasdorp & 
Feldman, 2013) did not exhibit significantly compromised regeneration outcomes. As the pore 
sizes of d‐PTFE (less than 0.3 μm) barriers are much smaller than e‐PTFE (0.5–30 μm), d‐
PTFE barriers provide a superior resistance to bacterial penetration. A pore size of less than 
0.3 μm (Bartee & Carr, 1995) is impervious to bacteria, as the average size of bacteria is 
approximately 0.5–5.0 μm. A larger pore size allows for easy bacterial contamination once a 
membrane is exposed to the oral cavity. The presence of bacterial contamination compromises 
the integrity of the membrane and limits the regeneration process. Once compromised, the soft 
tissue begins to infiltrate the membrane, resulting in a much more difficult removal of the 
membrane and less favorable outcomes (Rakhmatia et al., 2013).  
Regarding GBR at peri‐implant dehiscence sites, our study analyzed five articles (Annibali 
et al., 2012; Fu et al., 2014; Nowzari & Slots, 1995; Park et al., 2008; Tawil et al., 2001) that 
included 87 surgical sites, and found 27% more defect reduction at sites without membrane 
exposure compared to those with exposures. This difference, however, is even more critical 
when considering absorbable (Fu et al., 2014; Park et al., 2008; Tawil et al., 2001) vs. 
nonresorbable membranes. As absorbable membranes are primarily metabolized through 
enzymatic degradation, once they become exposed, these membranes have a greater 
susceptibility to infection and a faster degradation rate. Membrane exposures compromise 
space maintenance and cell exclusion properties, leading to detrimental effects that are readily 
seen in subsequent outcomes. It has been reported that bacterial invasion of the exposed 
absorbable membrane could occur as early as 3 weeks (Simion et al., 1997). During the first 
week of exposure, the outer surface of the barrier is colonized by bacteria, and by week three 
to four, the bacteria have invaded the entire thickness of the membrane. Bacterial invasion 
results in membrane resorption and creation of irregular voids in the barrier, which degrade the 
functional integrity of the barrier. Even with the long‐lasting cross‐linked collagen barriers, Tal, 
Kozlovsky, Artzi, Nemcovsky, and Moses (2008) found that bone regeneration outcomes were 
compromised once membranes were exposed.  
Interestingly, one study (Park et al., 2008) found a significant difference in peri‐implant 
dehiscence defect reduction between sites with and without barrier exposure in a collagen 
membrane group but not in an ADM group. Four of six sites with ADM exposure were 
epithelialized after a 1‐month period. The authors attributed this favorable outcome to the 
polarized matrix nature of ADM, which consisted of a basal lamina for epithelial cell migration 
and an underlying porous dermal matrix for angiogenic cell ingrowth (Cummings, Kaldahl, & 
Allen, 2005). However, although the difference was not statistically significant, it is worth noting 
that 25% less dehiscence defect reduction was still detected in the exposed ADM group than 
the nonexposed group.  
Our study findings are consistent with several previously published human studies reporting on 
membrane exposure, which show early membrane removal and compromised bone 
regeneration (von Arx, Hardt, & Wallkamm, 1996; Proussaefs & Lozada, 2006). It has been 
demonstrated that the timely membrane removal within 4 weeks of membrane exposure could 
still potentially result in successful bone augmentation (Annibali et al., 2012; Proussaefs & 
Lozada, 2006). Annibali et al. (2012) treated patients with systemic antibiotic therapy (1 g 
amoxicillin–clavulanate, twice a day for 6 days) when membrane exposure occurred. The 
membrane was subsequently removed after reentry surgery, and the flap was closed. The 
graft was allowed to heal for an additional period ranging from 3 to 8 months. The study 
outcome showed a comparable amount of defect reduction between sites with and without 
membrane exposure. Therefore, proper management of membrane exposure could minimize 
the negative outcomes.  
Both peri‐implant and edentulous sites exhibit a significant decrease in regeneration outcomes 
if membranes become exposed. Therefore, it can be concluded that healing with primary 
intention is a crucial factor for GBR procedures. Chao et al. (2015) reported the soft tissue 
quality, flap flexibility, as well as the types of barrier membranes used have an important 
impact on wound opening. Ideally, an adequate amount of keratinized tissue, a thick tissue 
biotype, a deep vestibular depth, and high flap flexibility with a use of absorbable membranes 
might minimize the incidence of wound opening. The authors also reported that the use of 
nonresorbable membranes potentially has higher risk of membrane exposure compared to 
absorbable ones due to a tendency to revert to their original shape after being molded. 
However, our search did not identify clinical data on d‐PTFE or absorbable synthetic 
membranes; thus, the influence of exposure of these types of barriers after GBR procedures 
on clinical outcomes cannot be determined at this time.  
Other than membrane exposure, another important factor to be considered is that of soft tissue 
dehiscence at surgical sites. Two included studies (Fu et al., 2014; Park et al., 2008) had a 
control group for grafting materials alone without utilizing a barrier membrane. Fu et al. (2014) 
reported a detrimental effect of wound dehiscence (−2.46% of defect height reduction and 
−15.48% of defect width reduction) on the surgical outcome. However, Park et al. (2008) did 
not find a significant difference in defect height reduction and bone thickness gain between the 
sites with and without wound dehiscence. The authors attributed this outcome to the use of the 
“sandwich bone augmentation” technique. Previous studies (Lorenzoni, Pertl, Keil, & 
Wegscheider, 1998; Lorenzoni et al., 2002) have confirmed that an absence of soft tissue 
dehiscence caused significant gain in the quantity of bone augmentation. Therefore, it can be 
concluded that both wound dehiscence and membrane exposure are contributing factors to 
unfavorable grafting outcomes. Clinically, achieving tension‐free primary closure and wound 
stability to minimize the chance of wound dehiscence and membrane exposure is important 
(Lim, Lin, Monje, Chan, & Wang, 2017).  
There are several limitations in the current study. First, only eight papers were included in the 
current study. Second, most analyses were presented with high heterogeneity due to the 
different study designs, follow‐up periods, materials used, etc. Third, all the included studies 
were deemed to have moderate to high risk of bias. This could be explained by the difficulty of 
conducting prospective studies to analyze outcomes on membrane exposure as this type of 
adverse event is hard to predict. Fourth, patient‐centered outcomes were not analyzed in the 
current review due to the limited data. Fifth, our study only identified data on e‐PTFE and 
collagen membranes. Future studies investigating the impact of membrane exposure with 
other types of currently available barriers, that is d‐PTFE, on clinical parameters are needed.  
5 CONCLUSION 
Based on the findings of the current study, membrane exposure after GBR procedures has a 
significant detrimental influence on the amount of bone augmentation. For GBR at edentulous 
sites, sites without membrane exposure achieved 74% more horizontal bone gain than sites 
with exposure. For peri‐implant dehiscence defects, the sites without membrane exposure had 
27% more defect reduction than sites with exposure. However, these outcomes are associated 
with collagen membranes and e‐PTFE barriers. Future studies investigating the impact of 
membrane exposure with other types of currently available barriers on clinical parameters are 
needed.  
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